Mårten Fernö
191 – 200 of 256
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 1999
-
Mark
Estrogen receptor content in adenovirus type 9-induced rat mammary tumors
(
- Contribution to journal › Article
-
Mark
Vascular endothelial growth factor (VEGF) and urokinase plasminogen activator (uPA) are independent prognostic factors for distant recurrence in premenopausal node-negative breast cancer
(
- Contribution to journal › Published meeting abstract
- 1998
-
Mark
Genetic aberrations in hypodiploid breast cancer: frequent loss of chromosome 4 and amplification of cyclin D1 oncogene
(
- Contribution to journal › Article
-
Mark
Proliferative index obtained by DNA image cytometry. Does it add prognostic information in Auer IV breast cancer?
(
- Contribution to journal › Article
-
Mark
Steroid receptors in hereditary breast carcinomas associated with BRCA1 or BRCA2 mutations or unknown susceptibility genes
(
- Contribution to journal › Article
-
Mark
Different calculation methods for flow cytometric S-phase fraction: prognostic implications in breast cancer? The Swedish Society of Cancer Study Group
(
- Contribution to journal › Article
-
Mark
Urokinase plasminogen activator and flow cytometric S-phase fraction as prognostic indicators in breast cancer
(
- Contribution to journal › Published meeting abstract
- 1997
-
Mark
Flow cytometric S-phase fraction in soft-tissue sarcoma: prognostic importance analysed in 160 patients
(
- Contribution to journal › Article
-
Mark
Intra- and inter-laboratory reproducibility of estrogen and progesterone receptor enzyme immunoassay in breast cancer cytosol samples--a Swedish multicenter study. Swedish Society of Cancer Study Group
(
- Contribution to journal › Article
-
Mark
Prognostic implications of cytogenetic findings in kidney cancer
(
- Contribution to journal › Article